October 2020

October 19, 2020

Trial Results: Genomic study of 6000 NCI-MATCH cancer patients leads to new clinical trial benchmarks

The Journal of Clinical Oncology published new data from the NCI-MATCH precision medicine cancer trial that has broad relevance in medicine and provides a roadmap for future precision medicine trials
October 19, 2020

TMIST Breast Cancer Screening Trial Rebounds from COVID-19 Shutdown of Cancer Screenings

October accrual is on pace to be the highest month on record. Since July 1, TMIST has enrolled more patients than all other National Cancer Institute clinical trials combined. An unheard-of number (nearly 20%) are Black and African American women. Drs. Etta Pisano and Mitch Schnall provide the latest status of the trial and discuss its continuing relevance
October 19, 2020

Now Enrolling: EAQ191 / CARISMA for management of hypertension in patients with metastatic renal cell or thyroid cancer on anti-angiogenic tyrosine kinase inhibitors

This phase II study, led by Dr. Bonnie Ky, aims to generate the necessary data to inform a phase III randomized controlled trial with the potential to make a significant public health impact